Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Her doctor prescribed the cheaper, generic version of the weight-loss drug after her insurer ... to stop making compounded ...

A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans a ...

The U.S. Food and Drug Administration (FDA) recently approved Zepbound ... OSA symptoms while also promoting significant weight loss. Zepbound is an injectable prescription medication created ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

Novo Nordisk (NVO) said its popular diabetes drug Ozempic, or semaglutide, has been approved for the treatment of patients ...

The medication also promotes weight loss, with patients losing an average ... options and eligibility for savings programs. The FDA's approval of Zepbound provides a new approach to treatment ...